Proud partner of

MENACTRA VACCINE, VL 4MCG/.05ML (5/CT)

Description

Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
Do not administer this product intravenously or subcutaneously
Requires refrigeration

Product Specification Sheet

Additional information

Units of Measurement

,

Manufacturer

SANOFI PASTEUR

UNSPSC

51201610

Product Specification Sheet

https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_SANOFI_VAC_NO_MSDS_REQUIRED.pdf

SDS

SDS_SANOFI_VAC_NO_MSDS_REQUIRED.pdf

Product Category

Download and fill out the Security Pack

Fill out the Security Pack with your information and upload it below